Navigation Links
UT rheumatologists discover 2 genes related to disabling form of arthritis
Date:10/21/2007

ell as autoimmune thyroid disease/Graves Disease, breast cancer and multiple sclerosis. Reveille, the George S. Bruce, Jr. Professor in Arthritis and Other Rheumatic Diseases, said the most significant findings were in AS, a disease that generally strikes patients in their teens, 20s or 30s.

ARTS1 and IL23R show a new pathway of causation, Reveille said, and this could lead to new therapies for the arthritic condition, which can cause a complete fusion of the spine, leaving patients unable to straighten and bend.

The identification of the two new genes also could help physicians identify patients who are at the highest risk for developing AS.

For example, if you have a family member with AS, a simple blood test would be able to tell us if you are also at risk, Reveille said. We could offer screenings for people with back pain. In the past, the HLA-B27 test was all we had. Now we potentially have more tests.

Steve Haskew, who has lived with AS for thirty years, said the genetic discovery offers hope to patients especially those who are newly diagnosed.

When I first started experiencing problems lower back pain, the aching joints no one could tell me what was wrong, said Haskew, 59, co-leader of an AS support group that meets every other month at the UT Medical School at Houston. It took 10 years before a rheumatologist diagnosed me with AS. Back then, there werent many options. I was told to take anti-inflammatories and stay as active as possible. Its fascinating to see how far weve come and how much has been learned about the disease since then.

The research done by Reveille and his colleague Xiaodong Zhou, M.D., associate professor of medicine in Division of Rheumatology and Clinical Immunogenetics, was supported in part by the Center for Clinical and Translational Sciences (CCTS) at The University of Texas Health Science Center at Houston.

This is a success story for genetics work, and I think it wi
'/>"/>

Contact: Meredith Raine
Meredith.Raine@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Rheumatologists Underestimate the Patients Ability to Work
2. PRIMARY PULMONARY HYPERTENSION GENE DISCOVERED
3. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
4. OHSU Researchers Announce New Discovery
5. Poisonous Parkinsons molecule discovered
6. Discovery of bone gene
7. Genes for Vision discovered
8. Chemists Discover Cation Considered Too Unstable To Exist
9. New breast cancer genes discovered
10. Latest discovery on Autism
11. Bacterial discovery may help CF patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)..., ANN ARBOR, Mich.---The University of Michigan ...f Health to develop the world,s leading resource o...ng compounds that will ultimately take computer-ai...will house the data needed to improve computer pro...ial new drugs, said Heather Carlson, associate pro...
(Date:10/10/2008)... SUNNYVALE, Calif., Oct. 10 /PRNewswire-FirstCa...obal leader in the field of radiosurgery,today an...quarter fiscal,year 2009, ending September 27, 200... closes., A conference call to review the results...ill be hosted by Euan S. Thomson, Ph.D., president...
(Date:10/10/2008)... BALTIMORE, Oct. 10 /PRNewswire/ -- A nationall...treatment strategies for patients with breast,canc...reast Cancer,Strategies: From Biomarkers to Treatm...ness Month., It is challenging for practicing onc...s to stay up to date on the latest patient care,ad...
(Date:10/9/2008)... Let Them Hear Foundation hosts annual wine auc...amily venture, EAST PALO ALTO, Calif., Oct. 9 /PR...ls, California vintners, and local businesses and,...living in silence at the,fifth annual Crush the Si...Foundation at the Four Seasons Hotel, Silicon Vall...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Accuray Incorporated to Report First Quarter Fiscal Year 2009 Financial Results 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2Health News:Local Leaders Support Needy Individuals, Communities 2
...oject that allowed prisoners a safe way to sport t... ended in September 2006. Now, an AIDS activist ha...awa, outlining the benefits of tattoo parlors in p... of AIDS. It is estimated that nearly 17% of the ...
...ndful of nutrient-rich dried plums each day help k...s in postmenopausal women with osteoporosis or ost...y in the Florida State University College of Human...ssor Bahram H. Arjmandi is the principal investiga...
...s at the University of Pennsylvania School of Medi... of therapy for patients who suffer from high chol... issue of the New England Journal of Medicine (NEJ...ygous familial hypercholesterolemia (FH), a high-r...
...rich food and lack of exercise is lethal for the l...d as fatty liver disease,// it is characterized by...ebilitates the liver and could be a cause of scarr... liver. According to researchers, sedentary habit...
Other Medicine News:Health News:Can Prunes Reverse Bone Loss After Menopause? 2Health News:Can Prunes Reverse Bone Loss After Menopause? 3Health News:New Therapy to Treat Patients With Severely Elevated Cholesterol Levels 2Health News:New Therapy to Treat Patients With Severely Elevated Cholesterol Levels 3
(Date:10/9/2008)...ire-FirstCall/ -- Diamyd Medical reports,that the ...England Journal,of Medicine, has published an arti...iamyd(R) diabetes vaccine for type 1 diabetes., (...4/297194 ), The article is now available on the ...l be in print on October 30. It presents the,resul...
(Date:10/8/2008)...ers Research That May Offer New Hope to,Heart Fail...ionally, over 3,000 people are,waiting for a heart... half,of those will receive a transplant. Now, pio...is paving the way for how to treat congestive hear... News Release, go to:, http://www.prnewswire.com/m...
(Date:10/8/2008)...y of Poly-ICR as Vaccine Adjuvant, SAN DIEGO, Oct...icals,Corporation (TSX: NVN) today presented posit...etary Toll-like Receptor 3 agonist, Poly IC-Poly,A...2008 in Lyon, France.,Study results demonstrated P...the Toll-like Receptor 3 (TLR3) pathway. Data show...
(Date:10/7/2008)...ire/ -- McLaren Health Care and its Great,Lakes Ca...eading medical,minds to share the latest work unde...al cancer treatments. The October 11th symposium, ...en,s Sukamal Saha, M.D., an,award-winning surgical...r,colorectal cancer has gained worldwide recogniti...
Breaking Medicine Technology:Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2AARP Calls for Action on Top Consumer Priorities 21189 1AARP Calls for Action on Top Consumer Priorities 21189 2Death on the Net 3F Over 60 25 of Medicines Sold by Online Pharmacies are Fake 21187 1Death on the Net 3F Over 60 25 of Medicines Sold by Online Pharmacies are Fake 21187 2Death on the Net 3F Over 60 25 of Medicines Sold by Online Pharmacies are Fake 21187 3OrthoSynetics 28TM 29 Donates Body Armor to New Orleans Police Department 21185 1OrthoSynetics 28TM 29 Donates Body Armor to New Orleans Police Department 21185 2AHCA Alliance Praise New Bipartisan Bi Cameral Effort Urging Bush Administration to Forego Medicare Cuts 21183 1AHCA Alliance Praise New Bipartisan Bi Cameral Effort Urging Bush Administration to Forego Medicare Cuts 21183 2AHCA Alliance Praise New Bipartisan Bi Cameral Effort Urging Bush Administration to Forego Medicare Cuts 21183 3
...ire-FirstCall/ -- IDM,Pharma, Inc. today announced... clinical trial and data from the Phase II EP-2101...al trial will be,presented at the 2007 American So...ing in Chicago on June 1-5 2007. , , UVIDEM pre...ogical responses in patients with malignant, ...
...rstCall/ -- Lev,Pharmaceuticals, Inc. ("Lev" or th... patient treatment in the prophylactic portion of,...tor (C1-INH) for,hereditary angioedema (HAE). The ...aluated the efficacy and safety of C1-INH,replacem...rophylactic treatment to prevent HAE attacks. , Le...
Other Medicine Technology:IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 2IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 3IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 4IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 5IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 6Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 2Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 3Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 4
Duckbill. 3.5 mm tip. Light curve.
Duckbill type, sharp. 3 mm x 8 mm curved blade. Octagonal handle.
4 mm x 9 mm tip.
2 mm curved tip. Round handle. Designated most popular model or size.
Medicine Products: